Predictors of antitumor necrosis factor primary nonresponse and drug durability in pediatric inflammatory bowel disease.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of pediatric gastroenterology and nutrition"
DOI: 10.1002/jpn3.70160
Abstract: OBJECTIVES Antitumor necrosis factor (anti-TNF) therapies are first-line therapies for children with inflammatory bowel disease (IBD) (Crohn's disease [CD], ulcerative colitis [UC] and IBD-unclassified [IBD-U]). Limited studies describing anti-TNFs durability and loss of response in… read more here.
Keywords: disease; durability; anti tnf; primary nonresponse ... See more keywords